- Aethlon Medical (AEMD, Financial) to announce Q4 2025 financial results on June 26, 2025.
- Earnings call scheduled for the same day at 4:30 p.m. ET with a Q&A session.
- Replay of the call available until July 26, 2025, through various channels.
Aethlon Medical, Inc. (AEMD), a company focused on therapeutic solutions for cancer and infectious diseases, is set to release its fiscal fourth quarter 2025 financial results on June 26, 2025, at 4:15 p.m. ET. Interested parties can join the earnings conference call, which will be held at 4:30 p.m. ET the same day.
The conference call will include presentations from the management and a session for questions and answers. Participants are encouraged to pre-register online or join directly via toll-free line 1-844-836-8741 or international line 1-412-317-5442. A replay of the conference call will be available approximately one hour post-conclusion and remain accessible until July 26, 2025. Access is available through Aethlon’s website or by calling 1-877-344-7529 (domestic), 1-412-317-0088 (international), or 1-855-669-9658 (Canada) using replay ID 4903201.
Aethlon Medical is renowned for its development of the Hemopurifier®, a device designed to treat advanced cancer and life-threatening viral infections. The device has received a Breakthrough Device designation from the FDA, indicating its potential in addressing critical medical needs. For further information, potential investors and stakeholders are advised to visit Aethlon’s website.
